Trademark Overview
On Monday, June 2, 2025, a trademark application was filed for CELLREP with the United States Patent and Trademark Office. The USPTO has given the CELLREP trademark a serial number of 99213731. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Tuesday, October 21, 2025. This trademark is owned by CellRep Corporation. The CELLREP trademark is filed in the Computer & Software Services & Scientific Services, Personal and Legal & Social Services categories with the following description:
Platform as a service (PAAS) featuring computer software platforms for for data analysis, drug discovery, drug screening, and preclinical testing in the field of bioinformatics; Research and development in the field of bioinformatics; Research and development in the field of cancer treatment and diagnosis; Drug discovery services; Drug screening for scientific research purposes; Testing of pharmaceuticals for cell and gene therapies; Research and development in the field of cell reprogramming technology for therapeutic applications; Research and development in the field of epigenomic modification for cellular medicine; Research and development in the field of enhancing cell and gene therapies; Research and development in the field of immune cell enhancement and rejuvenation; Research and development in the field of cell therapy enhancement for treatment of cancer, viral infections, and autoimmune disorders; Research and development in the field of therapeutic kits and solutions for cel...
Licensing of intellectual property
